Triheptanoin reduces seizure susceptibility in a syndrome-specific mouse model of generalized epilepsy

TH Kim; K Borges; S Petrou; CA Reid

Journal article

Triheptanoin reduces seizure susceptibility in a syndrome-specific mouse model of generalized epilepsy

TH Kim, K Borges, S Petrou, CA Reid

Epilepsy Research | ELSEVIER | Published : 2013

DOI: 10.1016/j.eplepsyres.2012.09.016

Abstract

Triheptanoin is a triglyceride containing heptanoate, an odd-chained medium fatty acid that is metabolized to produce propionyl-CoA and subsequently C4 intermediates of the citric acid cycle and therefore capable of anaplerosis. These metabolic products are believed to underlie triheptanoin's anticonvulsant effects in rodent seizure models. Here we investigate the anticonvulsive effects of oral triheptanoin in a syndrome-specific genetic mouse model of generalized epilepsy based on the GABAAγ2(R43Q) mutation. Mice were fed a diet supplemented with triheptanoin from weaning for three weeks prior to electrocortical recordings. Occurrence and durations of spike and wave discharges (SWDs) were m..

View full abstract

University of Melbourne Researchers

Christopher Reid Author

Related Projects (4)

Epilepsy: Molecular basis and mechanisms in the era of functional genomics

The team comprises of neurologists with a special interest in epilepsy (both adult and child) molecular geneticists, physiologists and brain..

Epilepsy: Molecular basis and mechanisms in the era of functional genomics

The team comprises of neurologists with a special interest in epilepsy (both adult and child) molecular geneticists, physiologists and brain..

Epilepsy: Molecular basis and mechanisms in the era of functional genomics

The team comprises of neurologists with a special interest in epilepsy (both adult and child) molecular geneticists, physiologists and brain..

Can we stop epilepsy from occurring in susceptible people

Epilepsy is a serious condition having a massive impact on individuals and the community at large. Our understanding of the genetic causes o..

Grants

Awarded by Australian Research Council

Funding Acknowledgements

This study was supported by the National Health and Medical Research Council of Australia (Grant numbers 400121, 628520 and 631541). CAR was also supported by an Australian Future Fellowship, Australian Research Council (#FT0990628). SP was supported by a NHMRC fellowship. The Florey Neuroscience Institutes are supported by Victorian State Government Infrastructure Funds.